Brasilixanthone BCAS# 84002-57-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 84002-57-3 | SDF | Download SDF |
PubChem ID | 5324261 | Appearance | Yellow powder |
Formula | C23H20O6 | M.Wt | 392.4 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 10,22-dihydroxy-7,7,18,18-tetramethyl-8,13,17-trioxapentacyclo[12.8.0.03,12.04,9.016,21]docosa-1(22),3(12),4(9),5,10,14,16(21),19-octaen-2-one | ||
SMILES | CC1(C=CC2=C(O1)C=C3C(=C2O)C(=O)C4=C(O3)C=C(C5=C4C=CC(O5)(C)C)O)C | ||
Standard InChIKey | CPBXNYZFGKIZDX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C23H20O6/c1-22(2)7-5-11-14(28-22)10-16-18(19(11)25)20(26)17-12-6-8-23(3,4)29-21(12)13(24)9-15(17)27-16/h5-10,24-25H,1-4H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Brasilixanthone B Dilution Calculator
Brasilixanthone B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5484 mL | 12.7421 mL | 25.4842 mL | 50.9684 mL | 63.7105 mL |
5 mM | 0.5097 mL | 2.5484 mL | 5.0968 mL | 10.1937 mL | 12.7421 mL |
10 mM | 0.2548 mL | 1.2742 mL | 2.5484 mL | 5.0968 mL | 6.371 mL |
50 mM | 0.051 mL | 0.2548 mL | 0.5097 mL | 1.0194 mL | 1.2742 mL |
100 mM | 0.0255 mL | 0.1274 mL | 0.2548 mL | 0.5097 mL | 0.6371 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 22-Epiinotodiol
Catalog No.:BCX0227
CAS No.:64907-49-9
- 1,3,5,7-Tetrahydroxy-8-prenylxanthone
Catalog No.:BCX0226
CAS No.:444004-76-6
- 1,6,8-Trihydroxy-2,7-dimethoxy-3-methylanthraquinone
Catalog No.:BCX0225
CAS No.:2366153-27-5
- Phenacetamide
Catalog No.:BCX0224
CAS No.:103-81-1
- 4-(1-Ethoxy-2-hydroxyethyl)benzene-1,2-diol
Catalog No.:BCX0223
CAS No.:1190632-33-7
- 3β,5α-Dihydroxystigmastan-6-one
Catalog No.:BCX0222
CAS No.:55051-78-0
- Fornicin A
Catalog No.:BCX0221
CAS No.:908588-41-0
- Cyclo(L-Pro-L-Ile)
Catalog No.:BCX0220
CAS No.:57089-60-8
- Cyclo(L-Pro-L-Val)
Catalog No.:BCX0219
CAS No.:2854-40-2
- Demethylmangostanin
Catalog No.:BCX0218
CAS No.:2289591-37-1
- Cyclo(L-Leu-L-Pro)
Catalog No.:BCX0217
CAS No.:2873-36-1
- 25,26,27-Trinor-3α-hydroxycycloartan-24-oic acid
Catalog No.:BCX0216
CAS No.:1300747-31-2
- Makisterone A
Catalog No.:BCX0229
CAS No.:20137-14-8
- Apigenin 6-C-(2-O-feruloyl)glucoside 8-C-glucoside
Catalog No.:BCX0230
CAS No.:1287786-63-3
- Fibleucin
Catalog No.:BCX0231
CAS No.:24278-14-6
- N-Acetylnornuciferine
Catalog No.:BCX0232
CAS No.:1942-03-6
- Tinospin E
Catalog No.:BCX0233
CAS No.:1582321-96-7
- Turmeronol B
Catalog No.:BCX0234
CAS No.:131651-38-2
- Aristolodione
Catalog No.:BCX0235
CAS No.:109771-09-7
- Ciwujianoside C2
Catalog No.:BCX0236
CAS No.:114892-56-7
- Mckeanianone B
Catalog No.:BCX0237
CAS No.:2035475-14-8
- 1-O-β-D-Glucopyranosylpaeonisuffrone
Catalog No.:BCX0238
CAS No.:1003888-20-7
- Pteroside B
Catalog No.:BCX0239
CAS No.:29774-74-1
- Kaempferol 3-O-neohesperidoside 7-O-glucoside
Catalog No.:BCX0240
CAS No.:78527-48-7
Metabolic Profile and Root Development of Hypericum perforatum L. In vitro Roots under Stress Conditions Due to Chitosan Treatment and Culture Time.[Pubmed:27148330]
Front Plant Sci. 2016 Apr 19;7:507.
The responses of Hypericum perforatum root cultures to chitosan elicitation had been investigated through (1)H-NMR-based metabolomics associated with morpho-anatomical analyses. The root metabolome was influenced by two factors, i.e., time of culture (associated with biomass growth and related "overcrowding stress") and chitosan elicitation. ANOVA simultaneous component analysis (ASCA) modeling showed that these factors act independently. In response to the increase of biomass density over time, a decrease in the synthesis of isoleucine, valine, pyruvate, methylamine, etanolamine, trigonelline, glutamine and fatty acids, and an increase in the synthesis of phenolic compounds, such as xanthones, epicatechin, gallic, and shikimic acid were observed. Among the xanthones, Brasilixanthone B has been identified for the first time in chitosan-elicited root cultures of H. perforatum. Chitosan treatment associated to a slowdown of root biomass growth caused an increase in DMAPP and a decrease in stigmasterol, shikimic acid, and tryptophan levels. The histological analysis of chitosan-treated roots revealed a marked swelling of the root apex, mainly due to the hypertrophy of the first two sub-epidermal cell layers. In addition, periclinal divisions in hypertrophic cortical cells, resulting in an increase of cortical layers, were frequently observed. Most of the metabolic variations as well as the morpho-anatomical alterations occurred within 72 h from the elicitation, suggesting an early response of H. perforatum roots to chitosan elicitation. The obtained results improve the knowledge of the root responses to biotic stress and provide useful information to optimize the biotechnological production of plant compounds of industrial interest.
Dichromenoxanthones from Tovomita brasiliensis.[Pubmed:11190402]
Phytochemistry. 2000 Dec;55(7):815-8.
Two dichromenoxanthones [1,6-dihydroxy-6',6'-dimethylpyrano(2',3':3,4)-6'',6''-dimethylpyrano(2'',3'':7,8)xanthone (brasilixanthone A) and 1,6-dihydroxy-6',6'-dimethylpyrano(2',3':2,3)-6'',6''-dimethylpyrano(2'',3'':7,8)xanthone (Brasilixanthone B)], along with betulinic acid, friedelin, sitosterol and stigmasterol were isolated from the roots and stems of Tovomita brasiliensis. Their structures were characterized on the basis of 1H and 13C NMR spectral data, including 2D NMR experiments.